4. Critical limb ischemia. Literature review (part 1)

Authors

  • T.K. Tajibayev Kazakh-Russian Medical University, Almaty, Kazakhstan, International Medical Center«Private Clinic Almaty», Almaty, Kazakhstan
  • V.M. Madyarov Kazakh-Russian Medical University, Almaty, Kazakhstan
  • A.A. Baubekov International Medical Center«Private Clinic Almaty», Almaty, Kazakhstan
  • I.Y. Sagatov A.N.Syzganov National Scientfic Center of Surgery, Almaty, Kazakhstan
  • A.Zh. Matkerimov A.N.Syzganov National Scientfic Center of Surgery, Almaty, Kazakhstan
  • A.S. Tergeussizov A.N.Syzganov National Scientfic Center of Surgery, Almaty, Kazakhstan
  • M.A. Zhakubayev A.N.Syzganov National Scientfic Center of Surgery, Almaty, Kazakhstan
  • M. Khanchi A.N.Syzganov National Scientfic Center of Surgery, Almaty, Kazakhstan

Downloads

Abstract

Critical limb ischemia (CLI) is the final stage of peripheral arterial disease which may lead to the chronic restpain, loss of tissues and limbs. Despite the active development of new technologies, including endovascular and open surgical methods of treatment, and the development of various type of guidelines, CLI still remains an unresolved burden of vascular surgery around the world. In the first part of this review, we described the problem of PAD, in particular, critical lower limb ischemia and the role of diabetes mellitus in the progression of these pathologies. In addition, we tried to reveal the statistics of «small» and «large» amputations in different regions of the world, as well as their social and economic significance.

Keywords

critical limb ischemia, peripheral artery diseases, diabetes mellitus, atherosclerosis, CLI, PAD

References

  1. Faglia E., Paola L.D., Clerici G., Clerissi J., Graziani, et al. Peripheral angioplasty as the first-choice revascularization procedure in diabetic patients with critical limb ischemia: prospective study of 993 consecutive patients hospitalized and followed between 1999 and 2003. J Vacs Endovasc Surg. 2005;29(6):620-627
  2. Chantelau E., Lee K.M., Jungblut R. Association of below-knee atherosclerosis to medial arterial calcification in diabetes mellitus. Diabetes Res Clin Pract. 1995;29(3):169-172
  3. Global Burden of Disease Study 2015. Global burden of disease study 2015 (GBD 2015) results. Seattle: Institute for Health Metrics and Evaluation (IHME), University of Washington
  4. International Diabetes Federation. IDF diabetes Atlas. 8th edn. 2017
  5. Brownrigg J.R., Hinchliffe R.J., Apelqvist J., Boyko E.J., Fitridge R., Mills J.L., Reekers J., Shearman C.P., Zierler R.E., Schaper N.C.; International Working Group on the Diabetic Foot. Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: a systematic review. Diabetes Metab Res Rev. 2016;32(suppl 1):128–135. doi:10.1002/dmrr.2704
  6. Beckman J.A., Creager M.A., Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570–2581. doi:10.1001/jama.287.19.2570
  7. Puzin S.N., Balabolkin M.I., Tselina M.E., Disability due to diabetes in young people and medical and social rehabilitation [Invalidnost’ vsledstvie saharnogo diabeta u lic molodogo vozrasta i mediko-social’naja reabilitacija]. Abstract. 2003
  8. Pickwell, K.M., Siersma, V.D., Kars M. et al. (2013). Diabetic foot disease: impact of ulcerlocation on ulcer healing. Diabetes Metab. Res. Rev. 29: 377–383
  9. Jupiter D.C., Thorud J.C., Buckley C.J., and Shibuya N. (2016). The impact of foot ulceration and amputation on mortality in diabetic patients. I: from ulceration to death, asystematic review. Int. Wound J. 13: 892–903
  10. American Diabetes Association, ADA, Cardiovascular disease and risk management: standards of medical care in Diabetes-2018, Diabetes Care 41 (2018) S86eS104; Prospective Studies Collaboration, Asia Pacific Cohort Studies Collaboration, Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980 793 adults from 68 prospective studies, Lancet Diabetes Endocrinol, 2018
  11. Shu J., Santulli G. Update on peripheral artery disease: Epidemiology and evidence-based facts, Atherosclerosis (2018)
  12. Fowkes F.G., Rudan D., Rudan I., Aboyans V., Denenberg J.O., McDermott M.M., Norman P.E., Sampson U.K., Williams L.J., Mensah G.A., Criqui M.H. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet 2013;382:1329–40
  13. Sheehan P. Peripheral arterial disease in people with diabetes: consensus statement recommends screening. Clin Diabetes. 2004;22:179–180
  14. Chantelau E., Lee K.M., Jungblut R. Association of below-knee atherosclerosis to medial arterial calcification in diabetes mellitus. Diabetes Res Clin Pract. 1995;29(3):169-172
  15. Camafort M., Alvarez-Rodrigues H., Munoz-Torrerot J.F. et al. Glucose control and outcome in patients with stable diabetes and previous coronary, cerebrovascular or peripheral artery disease. Finding from the FRENA registry. DiabetMed. 2011;28(1):73-80
  16. Norgren L., Hiatt W.R., Dormandy J.A. et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45(suppl S):S5–S67
  17. Dick F., Diehm N., Galimanis A., Husmann M., Schmidli J., Baumgartner I. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J VascSurg. 2007;45:751–761. doi:10.1016/j.jvs.2006.12.022
  18. Benoit E., O’Donnell T.F. Jr, Kitsios G.D., Lafrati M.D. Improved amputation-free survival in unreconstructable critical limb ischemia and its implications for clinical trial design and quality measurement. J VascSurg 2012;55(3)781–9
  19. Nehler M.R., Duval S., Diao L., Annex B.H., Hiatt W.R., Rogers K., Zakharyan A., Hirsch A.T. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J VascSurg. 2014;60:686–95.e2. doi:10.1016/j.jvs.2014.03.290
  20. American Cancer Society. Cancer Facts & Statistics. 2019
  21. Nehler M.R., Duval S., Diao L., Annex B.H., Hiatt W.R., Rogers K., Zakharyan A., Hirsch A.T. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J VascSurg. 2014;60:686–95.e2. doi:10.1016/j.jvs.2014.03.290
  22. Shestakova М.V., Dedov I.I. Diabetes mellitus and chronic kidney disease [Saharnyj diabet i hronicheskaja bolezn’ pochek] - M. : Medical Information Agency, 2009. – 482 p
  23. Suntsov Yu.I. et al. Epidemiology of diabetes mellitus and forecast of its prevalence in the Russian Federation [Jepidemiologija saharnogo diabeta i prognoz ego rasprostranennosti v rossijskoj federacii], 2011
  24. Moxey P.W., Gogalniceanu P., Hinchliffe R.J., Loftus I.M., Jones K.J., Thompson M.M., et al. Lower extremity amputationsda review of global variability in incidence. Diabet Med 2011;28:1144e53
  25. Narres M., Kvitkina T., Claessen, H. et al. (2017). Incidence of lower extremity amputations in LITERATURE REVIEW (PART 1) the diabetic compared with the non-diabetic population: a systematic review. PLoS One 12: e0182081
  26. Sidawy A.N., Perler B.A. Rutherford’s vascular surgery and endovascular therapy. Philadelphia, PA: Elsevier; 2019
  27. Trautner C., Haastert B., Giani G., Berger M. Incidence of lower limb amputations and diabetes. Diabetes Care. 1996;19(9):1006–9
  28. Vamos EP, Bottle A, Majeed A, Millett C. Trends in lower extremity amputations in people with and without diabetes in England, 1996–2005. DiabetesResClinPract. 2010;87(2):275–82
  29. Ziegler-Graham K., MacKenzie E.J., Ephraim P.L., Travison T.G., Brookmeyer R. Estimating the prevalence of limb loss in the United States: 2005 to 2050. Arch Phys Med Rehabil 2008;89: 422-9
  30. Goldberg J.B., Goodney P.P., Cronenwett J.L., Baker F. The effect of risk and race on lower extremity amputations among Medicare diabetic patients. J VascSurg. 2012;56:1663–1668. doi:10.1016/j.jvs.2012.05.100
  31. Goodney P.P., Beck A.W., Nagle J., Welch H.G., Zwolak R.M. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg. 2009;50:54–60. doi:10.1016/j.jvs.2009.01.035
  32. Agarwal S.., Sud K., Shishehbor M.H. Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: from 2003-2011. J Am Coll Cardiol. 2016;67:1901–1913. doi:10.1016/j.jacc.2016.02.040
  33. Kröger K., Berg C., Santosa F., Malyar N., Reinecke H: Lower limb amputation in Germany – an analysis of data from the German Federal Statistical Office between 2005 and 2014. DtschArzteblInt 2017; 114: 130–6. DOI:10.3238/arztebl.2017.0130
  34. Huxley R., Barzi F., and Woodward M. (2006). Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. BMJ 332: 73–78
  35. Jaff M.R., Cahill K.E., Yu A.P., Birnbaum H.G., Engelhart L.M. Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial disease. AnnVascSurg. 2010;24:577–587. doi:10.1016/j.avsg.2010.03.01
  36. Huang E.S., Basu A., O’Grady M., Capretta J.C. Projecting the future diabetes population size and related costs for the U.S. Diabetes Care. 2009;32:2225–2229
  37. Jaff M.R., Cahill K.E., Yu A.P., Birnbaum H.G., Engelhart L.M. Clinical outcomes and medical care costs among medicare beneficiaries receiving therapy for peripheral arterial disease. Ann Vasc Surg. 2010;24:577–587. doi:10.1016/j.avsg.2010.03.015

Published

2022-11-23

Issue

No. 4 (2022)

Section

Статьи